Atrás
Rango del Día
$14.43
$15.00
Rango de 52 Semanas
$13.91
$28.00
Volumen
470,849
Promedio 50D / 200D
$16.56
/
$22.06
Cierre Anterior
$14.60
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 30.1 | 0.4 |
| P/B | 2.7 | 2.9 |
| ROE % | 9.3 | 3.7 |
| Net Margin % | 11.8 | 3.8 |
| Rev Growth 5Y % | 7.8 | 10.0 |
| D/E | 0.3 | 0.2 |
Puntos Clave
Revenue grew 7.80% annually over 5 years — modest growth
Debt/Equity of 0.32 — conservative balance sheet
Generating 21.44M in free cash flow
P/E of 30.09 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 4.59%
Crecimiento
Revenue Growth (5Y)
7.80%
Revenue (1Y)3.21%
Earnings (1Y)14.01%
FCF Growth (3Y)N/A
Calidad
Return on Equity
9.29%
ROIC7.02%
Net Margin11.78%
Op. Margin16.07%
Seguridad
Debt / Equity
0.32
Current Ratio1.74
Interest Coverage8.40
Valoración
P/E Ratio
30.09
P/B Ratio2.72
EV/EBITDA23.93
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.21% | Revenue Growth (3Y) | 2.46% |
| Earnings Growth (1Y) | 14.01% | Earnings Growth (3Y) | -3.98% |
| Revenue Growth (5Y) | 7.80% | Earnings Growth (5Y) | -0.01% |
| Profitability | |||
| Revenue (TTM) | 1.14B | Net Income (TTM) | 134.28M |
| ROE | 9.29% | ROA | 5.28% |
| Gross Margin | 28.99% | Operating Margin | 16.07% |
| Net Margin | 11.78% | Free Cash Flow (TTM) | 21.44M |
| ROIC | 7.02% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.32 | Current Ratio | 1.74 |
| Interest Coverage | 8.40 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 30.09 | P/B Ratio | 2.72 |
| P/S Ratio | 3.55 | PEG Ratio | 2.50 |
| EV/EBITDA | 23.93 | Dividend Yield | 0.00% |
| Market Cap | 4.04B | Enterprise Value | 4.38B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.14B | 1.10B | 1.09B | 983.68M | 843.92M |
| Net Income | 134.28M | 117.78M | 145.63M | 142.85M | 134.32M |
| EPS (Diluted) | 0.49 | 0.43 | 0.55 | 0.53 | 0.53 |
| Gross Profit | 330.33M | 302.32M | 339.89M | 319.80M | 265.41M |
| Operating Income | 183.08M | 161.14M | 200.72M | 192.43M | 162.23M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.54B | 2.33B | 2.07B | 1.66B | 1.42B |
| Total Liabilities | 1.06B | 924.43M | 938.93M | 663.79M | 577.18M |
| Shareholders' Equity | 1.49B | 1.40B | 1.13B | 996.13M | 842.07M |
| Total Debt | 470.70M | 428.97M | 396.59M | 218.37M | 244.29M |
| Cash & Equivalents | 130.54M | 98.27M | 69.60M | 228.74M | 411.04M |
| Current Assets | 934.40M | 880.12M | 861.89M | 845.78M | 865.97M |
| Current Liabilities | 535.57M | 477.47M | 574.39M | 462.50M | 338.62M |